DOI: 10.1101/471227Nov 16, 2018Paper

Integrative Pharmacogenomics Analysis of Patient Derived Xenografts

BioRxiv : the Preprint Server for Biology
Arvind Singh MerBenjamin Haibe-Kains

Abstract

One of the key challenges in cancer precision medicine is finding robust biomarkers of drug response. Patient-derived tumor xenografts (PDXs) have emerged as reliable preclinical models since they better recapitulate tumor response to chemo- and targeted therapies. However, the lack of standard tools poses a challenge in the analysis of PDXs with molecular and pharmacological profiles. Efficient storage, access and analysis is key to the realization of the full potential of PDX pharmacogenomic data. We have developed Xeva (XEnograft Visualization & Analysis), an open-source software package for processing, visualization and integrative analysis of a compendium of in vivo pharmacogenomic datasets. The Xeva package follows the PDX minimum information (PDX-MI) standards and can handle both replicate-based and 1x1x1 experimental designs. We used Xeva to characterize the variability of gene expression and pathway activity across passages. We found that only a few genes and pathways have passage specific alterations (median intraclass correlation of 0.53 for genes and positive enrichment score for 92.5% pathways). For example, activity of the mRNA 3'-end processing and elongation arrest and recovery pathways were strongly affected by...Continue Reading

Associated Software

Dec 31, 2018·Arvind Singh MerBenjamin Haibe-Kains

Related Concepts

Antineoplastic Agents
Biological Markers
DNA, Complementary
Malignant Neoplasms
Pharmaceutical Preparations
Gene Expression
Genes
Neoplasms
Epidermal Growth Factor Receptor
RNA, Messenger

Related Feeds

BioRxiv & MedRxiv Preprints

BioRxiv and MedRxiv are the preprint servers for biology and health sciences respectively, operated by Cold Spring Harbor Laboratory. Here are the latest preprint articles (which are not peer-reviewed) from BioRxiv and MedRxiv.